Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-14-000170

← back to feed
Filed
Aug 13, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jun 30, 2014 150M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$31.01K
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$1.33M
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$28.72K
Cash And Equivalents Q2 2014 · Jun 30, 2014 $560
Cash And Equivalents Q2 2014 · Dec 31, 2013 $499
Cash And Equivalents Q2 2014 · Jun 30, 2013 $483
Cash And Equivalents Q2 2014 · Dec 31, 2012 $699
Stockholders Equity Q2 2014 · Jun 30, 2014 −$2.87M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$2.68M
Total Liabilities Q2 2014 · Jun 30, 2014 $3.34M
Total Liabilities Q2 2014 · Dec 31, 2013 $3.17M
Current Assets Q2 2014 · Jun 30, 2014 $562
Current Assets Q2 2014 · Dec 31, 2013 $501
Total Assets Q2 2014 · Jun 30, 2014 $470.65K
Total Assets Q2 2014 · Dec 31, 2013 $484.16K
Sga Expense Q2 2014 · Jun 30, 2014 $107.26K
Sga Expense Q2 2014 · Jun 30, 2014 $183.93K
Sga Expense Q2 2014 · Jun 30, 2014 $2.69M
Sga Expense Q2 2014 · Jun 30, 2013 $97.99K
Sga Expense Q2 2014 · Jun 30, 2013 $182.83K
Net Income Q2 2014 · Jun 30, 2014 −$107.26K
Net Income Q2 2014 · Jun 30, 2014 −$183.93K
Net Income Q2 2014 · Jun 30, 2014 −$2.86M
Net Income Q2 2014 · Jun 30, 2013 −$97.99K
Net Income Q2 2014 · Jun 30, 2013 −$182.91K